Back
Explore every episode of the podcast Treating Blood Cancers
Dive into the complete episode list for Treating Blood Cancers. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Moving Forward: Physical Therapy in Cancer Survivorship | 23 Oct 2026 | 00:37:56 | |
Stefanie Losensky, PT, DPT, CLT, Brigham and Women’s Faulkner Hospital, Jamaica Plain, MA Recorded on October 8, 2026 Stefanie Losensky, PT, DPT, CLT Board-Certified Clinical Specialist in Oncologic Physical Therapy, Department of Rehabilitation Brigham and Women’s Faulkner Hospital Jamaica Plain, MA Join Stefanie Losensky, PT, DPT, CLT from the Department of Rehabilitation at Brigham and Women’s Faulkner Hospital for an insightful discussion on the role of physical therapy in cancer survivorship. Stefanie explores common physical challenges and examines the timing and integration of physical therapy throughout the cancer care continuum. She discusses evidence-based interventions that can improve function, mobility, and quality of life, while also addressing insurance coverage, access to rehabilitation services, and practical educational resources to support healthcare professionals. Mentioned on this episode:
Blood Cancer United Resources: | |||
| BPDCN: Diagnosis to Emerging Therapies | 13 Oct 2026 | 00:32:40 | |
Hannah Levavi, MD, Tisch Cancer Center at Mount Sinai Hospital, New York, NY Recorded on September 24, 2026 Hannah Levavi, MD Assistant Professor of Medicine, Division of Hematology & Medical Oncology Tisch Cancer Center at Mount Sinai Hospital New York, NY In this episode, join Dr. Hannah Levavi from the Tisch Cancer Center at Mount Sinai Hospital, as she explores the evolving landscape of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Dr. Levavi reviews the clinical presentation and key diagnostic features of BPDCN, along with current first-line treatment approaches. She also examines the role of stem cell transplantation and discusses emerging therapies, including targeted agents and CAR T-cell therapy. The episode concludes with a look at ongoing research and future directions aimed at improving outcomes for patients with BPDCN. Tune in for this informative discussion on this rare hematologic malignancy! Blood Cancer United Resources: | |||
| Caring for LGBTQI+ Patients with Cancer | 15 Sep 2026 | 00:35:35 | |
Jason Domogauer, MD, PhD, NYU Perlmutter Cancer Center, New York, NY Recorded on August 27, 2026 Jason Domogauer, MD, PhD Director, LGBTQ+ Cancer Care and Research Program, Perlmutter Cancer Center Assistant Director, Community Outreach and Engagement, Perlmutter Cancer Center Director, Community Outreach and Engagement, Department of Radiation Oncology; Assistant Professor, Department of Radiation Oncology NYU Langone Health New York, NY Join us for an insightful conversation with Dr. Jason Domogauer from NYU Perlmutter Cancer Center as we explore the unique challenges and disparities faced by LGBTQI+ individuals across the cancer continuum. Dr. Domogauer discusses the psychosocial, clinical, and communication needs of LGBTQI+ patients with cancer, as well as strategies for delivering inclusive, affirming care. He also shares approaches to fostering welcoming healthcare environments, and highlights resources for both clinicians and patients. Tune in to this thoughtful discussion on advancing equitable, patient-centered cancer care. Mentioned on this episode: Blood Cancer United Resources: | |||
| Strengthening Bereavement Care in Oncology | 28 Aug 2026 | 00:34:51 | |
Ramy Sedhom, MD, FASCO, University of Pennsylvania, Plainsboro, NJ Recorded on August 13, 2026 Ramy Sedhom, MD, FASCO Associate Professor, Clinical Medicine, Division of Hematology/Oncology Director, Program in Geriatric Oncology & Supportive Care Innovation and the Center for Cancer and Aging at the Penn Center for Cancer Care Innovation University of Pennsylvania Plainsboro, NJ In this episode, Dr. Ramy Sedhom from the University of Pennsylvania explores the role of bereavement support in oncology care. He discusses how clinicians can support patients’ families after a loss, recognize when grief may require additional intervention, and incorporate meaningful bereavement practices into routine care. The conversation also examines the impact of patient loss on healthcare professionals and offers practical strategies to reduce clinician moral distress and burnout. Tune in today for this thoughtful conversation! Mentioned on this episode:
Blood Cancer United Resources: | |||
| Waldenström macroglobulinemia: What to Know in Practice | 10 Jul 2026 | 00:36:03 | |
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN Recorded on June 23, 2026 Stephen Ansell, MD, PhD Division Chair, Hematology Mayo Clinic Rochester, MN Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today! Blood Cancer United Resources: | |||
| Mastocytosis: What Clinicians Need to Know | 25 Jun 2026 | 00:34:29 | |
Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY Recorded on June 2, 2026 Marina Kremyanskaya, MD, PhD Associate Professor Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York, NY Join Dr. Marina Kremyanskaya from the Icahn School of Medicine at Mount Sinai in this expert discussion on mastocytosis, including an overview of the disease, key signs and symptoms, and current diagnostic criteria with a focus on relevant genetic mutations. She discusses recently approved therapies, emerging treatment approaches, and ongoing clinical trials that are shaping future treatment. The episode also covers approaches to managing complications, addressing treatment-related side effects, and delivering patient-centered care. Don’t miss this informative episode! Blood Cancer United Resources: | |||
| CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support | 15 Jun 2026 | 00:42:04 | |
Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL Recorded on May 28, 2026 Tara Gregory, MD President Colorado Blood Cancer Institute Denver, CO Jay Spiegel, MD Assistant Professor Division of Transplant and Cellular Therapy University of Miami Sylvester Comprehensive Cancer Center Miami, FL In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma and myeloma. They provide a practical overview of CAR-T, including currently approved indications, importance of early referral, patient selection considerations, and strategies for engaging patients in treatment discussions. The conversation also covers key aspects of toxicity management and post-treatment monitoring, while addressing current limitations of CAR-T therapy and future directions that may further expand its role in patient care. Tune in today for this exciting episode! Blood Cancer United Resources:
This episode is supported by Bristol Myers Squibb, Johnson & Johnson & Legend Biotech, and Kite, a Gilead Company. | |||
| Optimizing HSCT in Blood Cancers | 02 Jun 2026 | 00:38:40 | |
Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA Recorded on May 12, 2026 Lori Muffly, MD, MS Professor of Medicine Division of Blood and Marrow Transplantation & Cellular Therapy Stanford Medicine Stanford, CA In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next. Mentioned on this episode: Additional Blood Cancer United Resources: | |||
| Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care | 08 May 2026 | 00:35:22 | |
Mayra Allen, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Recorded on April 23, 2026 Mayra Allen, PhD Clinical Psychologist, Psycho-Oncology Service UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, CA Join us for an insightful conversation with Mayra Allen, PhD, clinical psychologist at UCSF’s Helen Diller Family Comprehensive Cancer Center, as we explore actionable strategies for supporting couples, caregivers, and families navigating cancer care. This episode examines practical communication approaches, the evolving role of care partners, and ways to help families manage complex situations. The discussion also addresses important yet often overlooked topics, including changes in intimacy, the impact of cultural perspectives across the cancer journey, and resources to support clinicians in delivering whole person oncology care. Tune in to this thoughtful discussion today! Mentioned on this episode: Additional Blood Cancer United Resources: | |||
| Driving Progress in AML | 23 Apr 2026 | 00:34:20 | |
David Sallman, MD, Moffitt Cancer Center, Tampa, FL Recorded on April 9, 2026 David Sallman, MD Associate Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL In this exciting episode, Dr. David Sallman from Moffitt Cancer Center takes a deep dive into acute myeloid leukemia (AML) and the advances transforming patient care. The discussion spans newly approved therapies, including menin inhibitors, as well as promising approaches under investigation in clinical trials, and explores how these innovations are influencing treatment selection, transplantation, and the management of side effects and complications in today’s AML landscape. Tune in today for expert insight into what’s shaping the future of AML care. Additional Blood Cancer United Resources:
This episode is supported by Kura Oncology, Inc. | |||
| Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment | 13 Apr 2026 | 00:34:15 | |
Matthew Loscalzo, LCSW, APOS Fellow, City of Hope, Duarte, CA Recorded on March 30, 2026 Matthew Loscalzo, LCSW, APOS Fellow Founding Executive Director and Professor Emeritus of Supportive Care Medicine and Professor of Population Sciences City of Hope Duarte, CA In this episode, licensed clinical social worker Matthew Loscalzo explores how survivors and healthcare professionals […] | |||
| Optimizing Outcomes in Myeloma | 24 Mar 2026 | 00:40:03 | |
Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC Recorded on March 10, 2026 Amy Pierre, MSN, ANP-BC Senior Clinical Director, Research Oncology, Flatiron Health Nurse Practitioner, Memorial Sloan Kettering Cancer Center New York, NY Peter Voorhees, MD Director, Outreach for Hematologic […] | |||
| Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology | 03 Mar 2026 | 00:39:55 | |
Matthew Kutny, MD, University of Alabama, Birmingham, AL, Julie Guillot, Pediatric AML parent, global advocate, and Blood Cancer United Volunteer, and Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC Recorded on February 19, 2026 Matthew Kutny, MD Professor of Pediatrics Director, Leukemia, Lymphoma and Histiocytosis Program Director, Pediatric Clinical Trials Office Institutional […] | |||
| What’s New and What’s Next in CLL | 17 Feb 2026 | 00:39:19 | |
Brad Kahl, MD, Siteman Cancer Center, St. Louis MO Recorded on January 27, 2026 Brad Kahl, MD Professor of Medicine Division of Oncology, Department of Medicine Washington University School of Medicine Director, Lymphoma Program Siteman Cancer Center St. Louis, MO In this episode, join Dr. Brad Kahl, Director of the Lymphoma Program at the Siteman […] | |||
| Guiding Fertility Care for Adolescents and Young Adults | 04 Feb 2026 | 00:37:46 | |
Pam Simon, MSN, CPNP, CPON, Stanford Adolescent and Young Adult Cancer Program (SAYAC), Palo Alto, CA and H. Irene Su, MD MSCE, University of California San Diego, San Diego, CA | |||
| Building Resilience: Burnout & Compassion Fatigue Tools for HCPs | 23 Jan 2026 | 00:36:41 | |
Building Resilience: Burnout & Compassion Fatigue Tools for HCPs Chelsey Winegar, LCSW, MBA, Intermountain Health, Murray, UT Recorded on January 8, 2026 Chelsey Winegar, LCSW, MBA Manager of Oncology Services Intermountain Health Murray, UT Join Chelsey Winegar, LCSW and Manager of Oncology Services at Intermountain Health in Murray, UT, as she breaks down the key differences […] | |||
| Key Insights from Attending ASH 2025 | 13 Jan 2026 | 00:33:51 | |
Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC Recorded on December 18, 2025 Lore Gruenbaum, PhD Chief Scientific Officer & Senior Vice President of Research Blood Cancer United Washington, DC Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from […] | |||
| Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know | 17 Dec 2025 | 00:30:48 | |
Raymond Mailhot, MD, MPH, University of Miami, Miami, FL Recorded on December 2, 2025 Raymond Mailhot, MD, MPH Department of Radiation Oncology University of Miami Miami, FL Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses […] | |||
| Hairy Cell Leukemia: Strategies for Improved Patient Outcomes | 20 Nov 2025 | 00:40:10 | |
Paul J. Hampel, MD, Mayo Clinic, Rochester, MN Recorded on November 4, 2025 Paul J. Hampel, MD Assistant Professor of Medicine Division of Hematology, Department of Medicine Mayo Clinic Rochester, MN In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, […] | |||
| Managing CML: What HCPs Need to Know | 06 Nov 2025 | 00:37:19 | |
Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on October 23, 2025 Michael J. Mauro, MD Director, Chronic Myeloid Leukemia Program Professor of Medicine, Leukemia Service Memorial Sloan Kettering Cancer Center New York, NY Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center […] | |||
| Understanding MRD: Insights for clinical practice and patient care | 10 Oct 2025 | 00:32:23 | |
Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA Recorded on September 25, 2025 Rahul Banerjee, MD, FACP Assistant Professor Fred Hutchinson Cancer Center Seattle, WA In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores […] | |||
| Pediatric Acute Leukemias: Focus on clinical trials for treatment | 19 Sep 2025 | 00:38:07 | |
Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA Recorded on September 9, 2025 Ann Collins, PA Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL) Blood Cancer United Washington, DC Kelly Laschinger, MSN, RN, […] | |||
| Charting the Course of ALL: From Diagnosis to Advances | 09 Jul 2025 | 00:36:46 | |
Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA Recorded on June 27, 2025 Catherine Lai, MD, MPH Associate Professor Physician Leader, Leukemia Clinical Research Unit University of Pennsylvania Perelman Center for Advanced Medicine Philadelphia, PA In this episode, Dr. Catherine Lai, from the University of Pennsylvania’s Perelman Center for […] | |||
| Strategies and Advances in AML | 12 Jun 2025 | 00:38:02 | |
Uma Borate, MBBS, MS, The Ohio State University, Columbus, OH Recorded on May 27, 2025 Uma Borate, MBBS, MS Associate Professor, Division of Hematology Acute Leukemia Clinical Research Disease Group Leader The Ohio State University Columbus, OH What’s changing in acute myeloid leukemia (AML)? Join Dr. Uma Borate from The Ohio State University in Columbus, […] | |||
| Advancing Care in Myeloproliferative Neoplasms (MPNs) | 29 May 2025 | 00:32:51 | |
Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH Recorded on May 13, 2025 Aaron Gerds, MD, MS Associate Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University School of Medicine Medical Director Case Comprehensive Cancer Center Clinical Research Office Cleveland, OH In this episode, Dr. Aaron Gerds from the Cleveland Clinic […] | |||
| A Collaborative Approach to Survivorship Care | 13 May 2025 | 00:32:39 | |
A Collaborative Approach to Survivorship Care Tessa Faye Flores, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY Recorded on April 24, 2025 Tessa Faye Flores, MDMedical Director, Cancer Screening and SurvivorshipRoswell Park Comprehensive Cancer CenterBuffalo, NY We are pleased to celebrate the 100th episode of Treating Blood Cancers with Dr. Tessa Flores from Roswell […] | |||
| MDS: Patient-Centered Approaches to Diagnosis and Treatment | 30 Apr 2025 | 00:42:38 | |
Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL Recorded on April 17, 2025 Mikkael A. Sekeres, MD, MS Chief, Division of Hematology Professor of Medicine Sylvester Comprehensive Cancer Center University of Miami Miami, FL Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center […] | |||
| Optimizing Care for Pediatric Blood Cancer | 18 Apr 2025 | 00:39:57 | |
Jeffrey Magee, MD, PhD, Washington University School of Medicine, St. Louis, MO Recorded on April 3, 2025 Jeffrey Magee, MD, PhD Elizabeth H. and James S. McDonnell III Professor of Pediatrics Director, McDonnell Pediatric Cancer Center Division of Pediatric Hematology and Oncology Washington University School of Medicine St. Louis, MO In this episode, we sit […] | |||
| Navigating Complex and Challenging Cases in Myeloma | 28 Mar 2025 | 00:44:25 | |
Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN Recorded on March 18, 2025 Angela Dispenzieri, MD Consultant, Division of Hematology Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine and Pathology Mayo Clinic Rochester, MN Join us as we dive into in the complex care of amyloid and myeloma with Dr. Angela […] | |||
| Beyond Burnout: Strategies for Empowering Healthcare Professionals | 13 Mar 2025 | 00:33:23 | |
Guy Maytal, MD, Forge Health and Weill Cornell Medicine, New York Recorded on February 20, 2025 Guy Maytal, MD Chief Medical Officer, Forge Health White Plains, NY Clinical Assistant Professor of Psychiatry, Weill Cornell Medicine New York, NY In this episode, Dr. Guy Maytal, from Forge Health and Weill Cornell Medicine in New York, explores […] | |||
| Key Strategies for HCPs: Supporting Caregivers and Care Partners | 28 Feb 2025 | 00:30:43 | |
Timothy Pearman, PhD, ABPP, Northwestern University Feinberg School of Medicine, Chicago, IL Recorded on February 6, 2025 Timothy Pearman, PhD, ABPP Director, Supportive Oncology Robert H. Lurie Comprehensive Cancer Center Professor, Department of Medical Social Sciences and Psychiatry & Behavioral Sciences Northwestern University Feinberg School of Medicine Chicago, IL Join us for an insightful episode […] | |||
| CAR-T in 2025: Advancements and the Road Ahead | 14 Feb 2025 | 00:38:12 | |
Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX Recorded on January 21, 2025 Jason Westin, M.D., MS, FACP Professor, Department of Lymphoma & Myeloma Lead, Lymphoma & Myeloma Service Line Director, Lymphoma Clinical Research Section Chief, Aggressive and Indolent Lymphoma MD Anderson Cancer Center Houston, TX In this episode, Dr. Jason Westin […] | |||
| Exploring Cutaneous T-Cell Lymphoma | 31 Jan 2025 | 00:32:08 | |
Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL Recorded on January 7, 2025 Jaehyuk (Jae) Choi, MD Jack W. Graffin Associate Professor of Dermatology and of Biochemistry and Molecular Genetics Northwestern University Feinberg School of Medicine Chicago, IL In this episode, Dr. Jaehyuk Choi from Northwestern University, explores Cutaneous T-Cell Lymphoma […] | |||
| Highlights from Attending ASH 2024 | 17 Jan 2025 | 00:51:17 | |
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2024 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide information […] | |||
| Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma | 19 Dec 2024 | 00:26:25 | |
Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL Recorded on November 21, 2024 Celeste Bello, MD Senior Member, Department of Malignant Hematology Moffitt Cancer Center Tampa, FL Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for […] | |||
| Understanding Mental Health in Cancer Survivorship | 09 Dec 2024 | 00:26:34 | |
Understanding Mental Health in Cancer Survivorship Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN Recorded on November 14, 2024 Lynn Gooden, BSN, RN, ONN-CG Oncology Navigation and Survivorship Manager Oncology Navigation Community Health […] | |||
| What’s New in Chronic Lymphocytic Leukemia (CLL)? | 19 Nov 2024 | 00:34:32 | |
Kerry A. Rogers, MD, The Ohio State University, Columbus, OH Recorded on October 29, 2024 Kerry A. Rogers, MD Associate Professor Division of Hematology The Ohio State University Columbus, OH Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, […] | |||
| The Role of the Healthcare Team in Biomarker Testing | 25 Oct 2024 | 00:30:16 | |
Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT Recorded on July 2, 2024 Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and […] | |||
| Decoding Medicare for Healthcare Professionals | 11 Oct 2024 | 00:35:19 | |
Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on September 20, 2024 Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the […] | |||
| Treating Hodgkin Lymphoma: What HCPs Need to Know | 27 Sep 2024 | 00:31:53 | |
Alex F. Herrera, MD, City of Hope Medical Center, Duarte, CA Recorded on June 27, 2024 Alex F. Herrera, MD Associate Professor Chief, Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation Associate Medical Director, Briskin Center for Clinical Research & City of Hope Duarte Clinical Trials Office City of Hope Medical Center Duarte, […] | |||
| Highlights from Attending the 2024 Society of Hematologic Oncology (SOHO) Annual Meeting | 20 Sep 2024 | 00:25:33 | |
Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA Recorded on September 9, 2024 Join us for this special episode, recorded at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of […] | |||
| Unpacking Mantle Cell Lymphoma | 13 Sep 2024 | 00:33:36 | |
Krish Patel, MD, Swedish Cancer Institute, Seattle, WA Recorded on June 6, 2024 Krish Patel, MD Director, Lymphoma Program Director, Hematologic Malignancies and Cellular Therapy Swedish Cancer Institute Seattle, WA Join us as Dr. Krish Patel from Swedish Cancer Institute explores mantle cell lymphoma, including the goals and latest advancements in treatment. He also provides […] | |||
| Clinical Perspectives on Hereditary Myeloid and Hematologic Disorders | 29 Aug 2024 | 00:25:12 | |
Ximena Jordan-Bruno, MD, University of Pennsylvania, Philadelphia, PA Recorded on June 4, 2024 Ximena Jordan-Bruno, MD Assistant Professor, Division of Hematology/Oncology University of Pennsylvania Philadelphia, PA Join us for this fascinating episode, where Dr. Ximena Jordan-Bruno from the University of Pennsylvania explores hereditary myeloid and hematologic disorders, covering their classifications, mutations, and related germline predisposition […] | |||
| Navigating Adult Survivorship Care | 16 Aug 2024 | 00:23:37 | |
Susan Hong, MD, Virginia Commonwealth University, Richmond, VA Recorded on May 21, 2024 Susan Hong, MD Director, Cancer Survivorship Program, Massey Comprehensive Cancer Center Associate Professor, School of Medicine Internal Medicine Virginia Commonwealth University Richmond, VA Tune in as Dr. Susan Hong, Cancer Survivorship Program Director at Virginia Commonwealth University’s Massey Cancer Center, discusses survivorship […] | |||
| Managing Oral and Dental Complications in Cancer Treatment | 11 Jul 2024 | 00:30:10 | |
David Dean, DDS, MSD, DABOM, FDS RCSEd, Fred Hutchinson Cancer Center and University of Washington School of Dentistry, Seattle, WA Recorded on April 25, 2024 David Dean, DDS, MSD, DABOM, FDS RCSEd Director, Oral Medicine Fred Hutchinson Cancer Center Clinical Associate Professor University of Washington School of Dentistry Seattle, WA Join us, as Dr. David […] | |||
| Exploring Survivorship Needs of Older Adults | 08 Jul 2024 | 00:33:56 | |
Cesar Rodriguez, MD, Mount Sinai Hospital, New York, NY Recorded on April 16, 2024 Cesar Rodriguez, MD Associate Professor of Medicine, Tisch Cancer Institute Clinical Director, Multiple Myeloma Center of Excellence Mount Sinai Hospital New York, NY Join us for an insightful episode with Dr. Cesar Rodriguez from Mount Sinai Hospital as he discusses the […] | |||
| Strategic Approaches to Pediatric and AYA Survivorship Care | 20 Jun 2024 | 00:28:59 | |
Karen E. Effinger, MD, MS, Children’s Healthcare of Atlanta, Atlanta, GA Recorded on April 4, 2024 Karen E. Effinger, MD, MS Associate Professor of Pediatrics Emory University School of Medicine Co-Director, Survivor Program Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta Atlanta, GA In this episode, Dr. Karen Effinger from Children’s Healthcare of […] | |||
| Insights and Updates on Navigating the AML Landscape | 07 Jun 2024 | 00:35:04 | |
Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX Recorded on March 28, 2024 Hagop M. Kantarjian, M.D. Professor and Chairman, Department of Leukemia Samsung Distinguished University Chair in Cancer Medicine MD Anderson Cancer Center, University of Texas Houston, TX Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center […] | |||
| CAR T-cell Therapy in 2024 | 12 Apr 2024 | 00:29:06 | |
Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO Recorded on March 12, 2024 Michael Tees, MD, MPH Director, Lymphoma Program Lymphoma Executive Committee Member, Sarah Cannon Research Institute Associate Member, Colorado Blood Cancer Institute Denver, CO Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses Chimeric antigen receptor (CAR) […] | |||
| Supporting Healthcare Professionals to Reduce Burnout | 14 Mar 2024 | 00:28:55 | |
Alfred Lee, MD, PhD, Yale University, New Haven, CT Recorded on February 22, 2024 Alfred Lee, MD, PhD Professor of Medicine, Yale School of Medicine Program Director, Hematology and Medical Oncology Fellowship Chief, Division of Classical Hematology, Yale Cancer Center Yale University New Haven, CT Join us for this important and engaging episode, as Dr. […] | |||
© My Podcast Data · Independent project · Data from Apple & Spotify